FIELD: medicine and gynecology.
SUBSTANCE: invention relates to medicine, in particular to gynecology, and is intended to predict the risk of progression of recurrent cervical intraepithelial neoplasias of low oncogenic risk associated with papillomavirus infection. In cervical biopsies, the colony-stimulating factor of macrophages M-CSF, plasma cells CD138 in the stroma, T-lymphocytes CD3 and natural killer cells CD56 in the cervical epithelium are assessed. Prognostic index PI is calculated according to the formula PI = 0.095 × Х1 + 0.053 × Х2 + 0.782 × Х3 – 0.387 × Х4 – 5.789. If PI is more than 0, it is concluded that there is a high risk of progression of recurrent cervical intraepithelial neoplasia of a low degree of oncogenic risk to a high one. If PI is less than 0, low risk is predicted.
EFFECT: invention allows predicting the progression of the pathological process in women with recurrent cervical intraepithelial neoplasias of a low degree of oncogenic risk and the risk of transition to a high degree of oncogenic risk.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF PROGRESSION OF LOW-GRADE CERVICAL SQUAMOUS INTRAEPITHELIAL LESION WITH UNDERLYING HUMAN PAPILLOMAVIRUS INFECTION | 2021 |
|
RU2766719C1 |
| METHOD OF PREDICTING PROGRESSION OF MILD INTRAEPITHELIAL NEOPLASIA IN WOMEN OF YOUNG AND FIRST PERIOD OF MATURE AGE | 2014 |
|
RU2572340C1 |
| METHOD FOR ASSESSING THE RISK OF PROGRESSION OF INTRAEPITHELIAL CERVICAL NEOPLASIA AND DEVELOPMENT OF CERVICAL CANCER BY DETERMINING THE LEVELS OF HUMAN MRNA GENES | 2015 |
|
RU2660360C2 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE CONDUCTED TREATMENT OF I-II DEGREE CERVICAL INTRAEPITHELIAL NEOPLASIAS | 2021 |
|
RU2773799C1 |
| METHOD FOR PREDICTING THE PROGRESS OF PAPILLOMAVIRUS INFECTION IN PATIENTS WITH CHRONIC RECURRENT INFLUENZA ASSOCIATED CERVICITIS | 2017 |
|
RU2646785C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS OF HIGH ONCOGENIC RISK | 2020 |
|
RU2754494C1 |
| METHOD FOR USING IMMUNOLOGICAL MARKERS FOR PREDICTION OF PROLIFERATIONS OF CERVICAL INTRAEPITHELIAL NEOPLASIAS ASSOCIATED WITH PAPILLOMAVIRUS INFECTION | 2012 |
|
RU2520746C1 |
| METHOD FOR TREATMENT OF CERVICAL INTRAEPITHELIAL GRADE I NEOPLASIA ASSOCIATED WITH HPV OF HIGH ONCOGENIC RISK, USING A CAVITATED SOLUTION OF PANAVIR | 2017 |
|
RU2682783C2 |
| DIAGNOSTIC TECHNIQUE FOR HYPERPROLIFERATIVE CONDITIONS AND METHOD FOR ASSESSING RISK OF CERVICAL CANCER ACCOMPANYING CERVICAL INTRAEPITHELIAL NEOPLASIA AND PAPILLOMA VIRUS CARRIER STATE BY DETERMINIG MRNA OF FUNCTIONAL HUMAN GENE COMPLEX | 2012 |
|
RU2532344C2 |
| METHOD FOR ASSESSING CONDITIONS OF PROLIFERATIVE CERVICAL DISEASES | 2012 |
|
RU2503960C1 |
